1 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2258578/roche-rhhby-alecensa-wins-fda-nod-for-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2258578
Apr 19, 2024 - Roche (RHHBY) has won FDA approval for Alecensa as an adjuvant treatment, following tumor resection for patients with ALK-positive non-small cell lung cancer.
zc:-8617360878836982662
0